Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-21

Clinical Trial Update: Restricting the Use of Artesunate Plus Amodiaquine Combination Therapy to Malaria Cases Confirmed by a Dipstick Test: A Cluster Randomised Control Trial [Phase 4]

View source ↗

Summary

A Phase 4 trial update restricts artesunate plus amodiaquine combination therapy to malaria cases confirmed by a dipstick test, using a cluster randomized desig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amodiaquine (Amodiaquine)
  • Artesunate (artesunate)

Snippet

Sponsor: Kintampo Health Research Centre, Ghana | Conditions: Malaria | Phase 4 | Status: COMPLETED